Position in BNTC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,185,027
+$2,603,321 QoQ
Shares Held
611,736
+16.7% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 86 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. BNTC ranks #201 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BNTC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,185,027 | 611,736 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,581,706 | 524,104 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,106,960 | 453,375 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $6,152,224 | 438,505 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,857,968 | 415,211 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,041,998 | 233,820 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,489,322 | 197,096 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $771,840 | 83,987 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $447,184 | 63,975 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $52,626 | 10,024 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $32,377 | 10,024 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,292 | 10,024 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,525 | 48,223 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,126 | 48,223 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,409 | 49,469 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $22,679 | 60,967 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $70,157 | 60,481 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $139,086 | 59,566 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $153,042 | 58,413 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $191,680 | 53,692 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $146,595 | 34,493 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $147,655 | 28,560 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||